Vital Art and Science, LLC
The mVT™ Service detects early visual function changes related to retinal diseases, which can lead to sooner treatment and better patient outcomes.
Vital Art and Science, LLC has developed the first FDA cleared smartphone-based home vision function monitor for those afflicted with degenerative eye diseases such as diabetic retinopathy (DR) and Age Related Macular Degeneration (AMD). These afflict over 25M people in both the US and Europe today. The mVT™ Service is by prescription only and provides an easy and accurate way for patients to test their vision at home .